CSIMarket
 


Amicus Therapeutics inc   (FOLD)
Other Ticker:  
 


Amicus Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



FOLD Gross Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 31.47 % 25.54 % 16.92 % 9.6 % 7.23 %
Seq. Revenue Change 12.93 % 8.65 % 9.41 % -2.07 % 7.84 %
Revenue In Millions $115.82 $102.56 $94.39 $86.27 $88.10
Gross Profit Margin 89.59 % 91.22 % 90.46 % 91.95 % 89.35 %
Gross Profit Margin Total Ranking # 712 # 1068 # 1186 # 1164 # 1498
Gross Profit In Millions $103.76 $93.56 $85.39 $79.33 $78.71
Y / Y Gross Profit Change 31.82 % 37.07 % 17.72 % 11.52 % 5.93 %
Seq. Gross Profit Change 10.91 % 9.56 % 7.64 % 0.78 % 15.32 %


Commenting fourth Quarter 2023 Gross Profit Margin
Amicus Therapeutics Inc has managed to improve its Revenue sequentially to $116 millions by 12.93 % faster than Gross Profit increase of 10.91 % to $104 millions, this led to contraction in Gross Profit Margin to 89.59 %, below company average.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 71 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 712, from total ranking in previous quarter at 1068.
Learn about Gross Margin
FOLD's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 72
Healthcare Sector # 124
Overall # 711

Gross Profit Margin Statistics
High Average Low
100 % 89.83 % 79.07 %
(Dec 31 2014)   (Sep 30 2018)




Other Gross Profit Margin Profitability Ratios
FOLD's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
FOLD's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for FOLD's Competitors
Gross Profit Margin Profit Margin for Amicus Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for FOLD's Customers

You may also want to know
FOLD's Annual Growth Rates FOLD's Profitability Ratios FOLD's Asset Turnover Ratio FOLD's Dividend Growth
FOLD's Roe FOLD's Valuation Ratios FOLD's Financial Strength Ratios FOLD's Gross Profit Growth
FOLD's Roa FOLD's Inventory Turnover Ratio FOLD's Growth Rates FOLD's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Blueprint Medicines Corporation  186.81 %$ 145.291 $ 77.776 
Royalty Pharma Plc  112.84 %$ 672.581 $ 596.068 
Abcellera Biologics Inc   100.00 %$ 9.178 $ 9.178 
Ac Immune Sa  100.00 %$ 14.801 $ 14.801 
Alpine Immune Sciences Inc   100.00 %$ 30.853 $ 30.853 
Altimmune Inc   100.00 %$ 0.037 $ 0.037 
Anaptysbio Inc   100.00 %$ 9.005 $ 9.005 
Aprea Therapeutics Inc   100.00 %$ 0.583 $ 0.583 
Arrowhead Pharmaceuticals Inc   100.00 %$ 3.551 $ 3.551 
Azitra Inc   100.00 %$ 0.203 $ 0.203 
Bicycle Therapeutics Plc  100.00 %$ 5.331 $ 5.331 
Biofrontera Inc   100.00 %$ 52.086 $ 52.086 
Capricor Therapeutics inc   100.00 %$ 12.088 $ 12.088 
Cymabay Therapeutics Inc   100.00 %$ 0.057 $ 0.057 
Checkpoint Therapeutics Inc   100.00 %$ 0.006 $ 0.006 
Chimerix Inc   100.00 %$ 0.004 $ 0.004 
Cnbx Pharmaceuticals Inc   100.00 %$ 0.089 $ 0.089 
Ensysce Biosciences Inc   100.00 %$ 0.671 $ 0.671 
Esperion Therapeutics inc   100.00 %$ 32.250 $ 32.250 
Foghorn Therapeutics Inc   100.00 %$ 5.769 $ 5.769 
Generation Bio Co   100.00 %$ 2.878 $ 2.878 
Glycomimetics Inc   100.00 %$ 0.010 $ 0.010 
G1 Therapeutics Inc   100.00 %$ 14.873 $ 14.873 
Hookipa Pharma inc   100.00 %$ 7.407 $ 7.407 
Werewolf Therapeutics Inc   100.00 %$ 1.501 $ 1.501 
Ironwood Pharmaceuticals inc   100.00 %$ 117.553 $ 117.553 
Intra cellular Therapies Inc   100.00 %$ 132.099 $ 132.099 
Jazz Pharmaceuticals Plc  100.00 %$ 1,011.935 $ 1,011.935 
Kronos Bio Inc   100.00 %$ 2.286 $ 2.286 
Keros Therapeutics Inc   100.00 %$ 14.898 $ 14.898 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com